Gabelli Funds’s NeoGenomics NEO Stock Holding History

Gabelli Funds’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$812K	Sell	109,500 -9,500	-8%	-$100K	0.01%	945
2025 Q4	$1.4M	Hold	119,000	–	–	0.01%	829
2025 Q3	$919K	Hold	119,000	–	–	0.01%	932
2025 Q2	$870K	Buy	119,000 +20,000	+20%	+$161K	0.01%	936
2025 Q1	$940K	Buy	99,000 +85,000	+607%	+$1.06M	0.01%	792
2024 Q4	$231K	Sell	14,000 -4,000	-22%	-$62.1K	﹤0.01%	1003
2024 Q3	$266K	Hold	18,000	–	–	﹤0.01%	974
2024 Q2	$250K	Hold	18,000	–	–	﹤0.01%	966
2024 Q1	$283K	Buy	+18,000	New	+$278K	﹤0.01%	953
2022 Q4	–	Sell	-28,000	Closed	-$241K	–	1241
2022 Q3	$241K	Sell	28,000 -20,000	-42%	-$199K	﹤0.01%	1118
2022 Q2	$391K	Sell	48,000 -700	-1%	-$6.68K	﹤0.01%	1067
2022 Q1	$592K	Buy	48,700 +4,000	+9%	+$84.2K	﹤0.01%	1017
2021 Q4	$1.52M	Hold	44,700	–	–	0.01%	787
2021 Q3	$2.16M	Sell	44,700 -1,000	-2%	-$46.3K	0.01%	715
2021 Q2	$2.06M	Buy	45,700 +500	+1%	+$22.2K	0.01%	746
2021 Q1	$2.18M	Sell	45,200 -14,560	-24%	-$758K	0.01%	706
2020 Q4	$3.22M	Sell	59,760 -5,940	-9%	-$268K	0.02%	589
2020 Q3	$2.42M	Sell	65,700 -22,800	-26%	-$848K	0.02%	629
2020 Q2	$2.74M	Buy	88,500 +28,500	+48%	+$790K	0.02%	584
2020 Q1	$1.66M	Sell	60,000 -10,000	-14%	-$300K	0.01%	679
2019 Q4	$2.05M	Sell	70,000 -3,000	-4%	-$71.4K	0.01%	724
2019 Q3	$1.4M	Sell	73,000 -54,190	-43%	-$1.27M	0.01%	797
2019 Q2	$2.79M	Sell	127,190 -5,412	-4%	-$119K	0.02%	684
2019 Q1	$2.71M	Sell	132,602 -12,022	-8%	-$209K	0.02%	692
2018 Q4	$1.82M	Sell	144,624 -185,113	-56%	-$2.76M	0.01%	752
2018 Q3	$5.06M	Sell	329,737 -32,196	-9%	-$445K	0.03%	567
2018 Q2	$4.75M	Sell	361,933 -406,067	-53%	-$4.47M	0.03%	575
2018 Q1	$6.27M	Buy	768,000 +291,600	+61%	+$2.36M	0.04%	488
2017 Q4	$4.22M	Buy	476,400 +111,400	+31%	+$1.03M	0.02%	610
2017 Q3	$4.06M	Sell	365,000 -358,014	-50%	-$3.48M	0.02%	623
2017 Q2	$6.48M	Buy	723,014 +209,219	+41%	+$1.66M	0.04%	490
2017 Q1	$4.05M	Buy	513,795 +353,795	+221%	+$2.88M	0.02%	606
2016 Q4	$1.37M	Buy	160,000 +20,000	+14%	+$171K	0.01%	870
2016 Q3	$1.15M	Sell	140,000 -40,000	-22%	-$336K	0.01%	894
2016 Q2	$1.45M	Sell	180,000 -265,000	-60%	-$2.12M	0.01%	859
2016 Q1	$3M	Buy	445,000 +150,000	+51%	+$987K	0.02%	672
2015 Q4	$2.32M	Sell	295,000 -154,357	-34%	-$1.13M	0.01%	733
2015 Q3	$2.58M	Sell	449,357 -113,400	-20%	-$702K	0.02%	704
2015 Q2	$3.04M	Sell	562,757 -107,054	-16%	-$552K	0.02%	697
2015 Q1	$3.13M	Buy	669,811 +97,757	+17%	+$425K	0.02%	701
2014 Q4	$2.38M	Sell	572,054 -12,946	-2%	-$59.5K	0.01%	757
2014 Q3	$3.05M	Buy	585,000 +85,000	+17%	+$437K	0.02%	705
2014 Q2	$1.66M	Buy	500,000 +225,000	+82%	+$748K	0.01%	795
2014 Q1	$954K	Sell	275,000 -65,800	-19%	-$247K	0.01%	871
2013 Q4	$1.23M	Buy	340,800 +30,800	+10%	+$107K	0.01%	823
2013 Q3	$930K	Buy	310,000 +151,100	+95%	+$426K	0.01%	859
2013 Q2	$632K	Buy	+158,900	New	+$606K	﹤0.01%	887

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Gabelli Funds's NEO Position: Q1 2026 in Review

Gabelli Funds reduced its NeoGenomics (NEO) stake by 8% in Q1 2026, selling an estimated $100K and leaving 109,500 shares worth $812K. The position accounts for 0.01% of the portfolio, ranked #945.

Gabelli Funds first reported a position in NEO in Q2 2013 and has held it in 47 quarters since. The position peaked at $6.48M in Q2 2017. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Gabelli Funds held 109,500 shares of NeoGenomics worth $812K as of Q1 2026.
Gabelli Funds sold 9,500 NeoGenomics shares in Q1 2026, an estimated $100K.
NeoGenomics made up 0.01% of Gabelli Funds's portfolio in Q1 2026, its #945 holding.
Gabelli Funds first reported a position in NeoGenomics in Q2 2013 and has held it in 47 quarters since.
Gabelli Funds's NeoGenomics position peaked at $6.48M in Q2 2017.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.